Heart Test Laboratories Inc. Common Stock (HSCS) - Total Assets
Based on the latest financial reports, Heart Test Laboratories Inc. Common Stock (HSCS) holds total assets worth $3.74 Million USD as of July 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see cash efficiency ratio of Heart Test Laboratories Inc. Common Stoc for how efficiently the company converts equity into cash flow.
Heart Test Laboratories Inc. Common Stock - Total Assets Trend (2020–2026)
This chart illustrates how Heart Test Laboratories Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See latest Heart Test Laboratories Inc. Common Stoc stock price today for real-time trading data and today's change.
Heart Test Laboratories Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (April 2026)
Heart Test Laboratories Inc. Common Stock's total assets of $3.74 Million consist of 49.1% current assets and 50.9% non-current assets. Explore Heart Test Laboratories Inc. Common Stoc current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 31.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $655.63 Million | 12.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.37 Billion | 45.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2026)
This chart illustrates how Heart Test Laboratories Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Heart Test Laboratories Inc. Common Stock's current assets represent 49.1% of total assets in 2026, a decrease from 78.6% in 2020.
- Cash Position: Cash and equivalents constituted 31.5% of total assets in 2026, up from 25.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 45.1% of total assets.
Heart Test Laboratories Inc. Common Stock Competitors by Total Assets
Key competitors of Heart Test Laboratories Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Vieworks Co. Ltd
KQ:100120
|
Korea | ₩351.89 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
Heart Test Laboratories Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 1.47 | 1.47 |
| Quick Ratio | -71.42 | 1.25 | 0.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.95 Million | $1.40 Million | $524.28K |
Heart Test Laboratories Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Heart Test Laboratories Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 70.85 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 124522.0% |
| Total Assets | $5.26 Billion |
| Market Capitalization | $14.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Heart Test Laboratories Inc. Common Stock's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Heart Test Laboratories Inc. Common Stock's assets grew by 124522.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Heart Test Laboratories Inc. Common Stock (2020–2026)
The table below shows the annual total assets of Heart Test Laboratories Inc. Common Stock from 2020 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-04-30 | $5.26 Billion | +124521.98% |
| 2025-04-30 | $4.22 Million | -55.56% |
| 2024-04-30 | $9.50 Million | +189.09% |
| 2023-04-30 | $3.29 Million | +57.33% |
| 2022-04-30 | $2.09 Million | +8.41% |
| 2021-04-30 | $1.93 Million | -1.46% |
| 2020-04-30 | $1.96 Million | -- |
About Heart Test Laboratories Inc. Common Stock
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related… Read more